Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic mesenchymal stem cells for lupus nephritis
2017-000391-28Phase 2Active
- Sponsor
- Fundación Instituto de Ciencias de la Salud de Castilla y León
- Start
- May 2017
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, double-blind trial of MSV alogénicas in lupus nephritis (LN) (2 arms), sponsored by Fundación Instituto de Ciencias de la Salud de Castilla y León. Primary endpoint: Full or partial response at week 24. Started May 2017; status: active.
02
Drugs
MSV alogénicas
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on 2017-000391-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000391-28.